Northwind Pharmaceuticals, Physician Dispensing

Physician Dispensing: Economics Part 1

Physician-Dispensing-Economics-Part-1One of the major drivers for doctors considering dispensing pharmaceuticals from their clinics is the potential revenue.  

The U.S. Bureau of Labor Statistics shows:

  • About 633,000 working doctors in the United States.
  • About half work in physician offices
  • 15% are self-employed
  • 40% or all working physicians are general practitioners
  • On average, general practice physicians earn about $166,400 per year

With reimbursements dropping (Medicare reimbursement dropped 5%), physicians are looking for creative ways to reduce costs and increase revenues.

Enter physician dispensing.

With physician dispensing, patients are offered prepackaged pharmaceuticals before they leave the office. One study shows that general practice physicians see almost 20 patients each day, many of them requiring a prescription. Offering patients medications before they leave the office not only simplifies access to medication and reduces errors, it provides an avenue of revenue that was previously only enjoyed by pharmacies. Yet for all of the benefits, it is estimated that just under 10,000 physicians dispense from their practices.

Physician dispensing just makes sense for businesses looking to increase revenue. Northwind Pharmaceuticals has solutions for all types of healthcare organizations, making the implementation of in-house dispensing seamless. Contact us today to learn how we can help you provide convenience to your patients while generating supplemental revenue!

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading